Hydrocodone Extended-Release Capsules and Sopamycetin Ophthalmic
Determining the interaction of Hydrocodone Extended-Release Capsules and Sopamycetin Ophthalmic and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hydrocodone
Brand name: Hysingla ER, Zohydro ER, Vantrela ER
Synonyms: Hydrocodone
Generic Name: chloramphenicol ophthalmic
Brand name:
Synonyms: Chloramphenicol (Ophthalmic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hydrocodone Extended-Release Capsules-Sopamycetin Otic
- Hydrocodone Extended-Release Capsules-Sorafenib
- Hydrocodone Extended-Release Capsules-Sorafenib Tosylate
- Hydrocodone Extended-Release Capsules-Sorbitol
- Hydrocodone Extended-Release Capsules-Sorbitol Irrigation Solution
- Hydrocodone Extended-Release Capsules-Sorbitol Solution
- Sopamycetin Ophthalmic-Hydrocodone Extended-Release Tablets
- Sopamycetin Ophthalmic-Hydrocodone Polistirex and Chlorpheniramine Polistirex Suspension
- Sopamycetin Ophthalmic-Hydrocodone, Chlorpheniramine, and Pseudoephedrine
- Sopamycetin Ophthalmic-Hydrocodone, Pseudoephedrine, and Guaifenesin
- Sopamycetin Ophthalmic-Hydrocortisone
- Sopamycetin Ophthalmic-Hydrocortisone (Systemic)